GlassScriptPhysician profile
Valal K George
NPI 1528023892
$3,517.38
in general payments reported to CMS, 2019-2025
32 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2021: $57.62 · 2022: $399 · 2023: $1,301 · 2024: $769 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,138 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,138.18 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $539.26 | 2023-2024 | Nanoknife |
| Ferring Pharmaceuticals INC. | $521.24 | 2019-2024 | Adstiladrin |
| Coloplast Corp | $287.58 | 2019-2024 | |
| Astellas Pharma US INC | $269.19 | 2019-2024 | Xtandi |
| Abbvie INC. | $206.13 | 2022-2025 | |
| Medtronic, INC. | $186.76 | 2021-2023 | Interstim |
| Myriad Genetic Laboratories, INC. | $172.67 | 2022-2023 | Prolaris |
| Antares Pharma, INC. | $152.22 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Teleflex LLC | $136.50 | 2023 | Urolift |
| Bioprotect Medical, INC. | $130.13 | 2025 | Bioprotect Balloon Implant System |
| Astrazeneca Pharmaceuticals LP | $111.59 | 2022-2024 | Lynparza |
| Janssen Scientific Affairs, LLC | $99.99 | 2022 | |
| Merck Sharp & Dohme LLC | $83.60 | 2022-2024 | Keytruda |
| Axonics, INC. | $78.13 | 2023 | Bulkamid |
| Sumitomo Pharma America, INC. | $74.93 | 2023-2024 | Gemtesa, Orgovyx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $73.31 | 2022-2024 | Xiaflex |
| Urogen Pharma, INC. | $50.96 | 2024 | |
| Pfizer INC. | $48.94 | 2019-2024 | |
| Tempus Ai, INC | $37.57 | 2024 | |
| Halozyme INC | $35.08 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.47 | 2023 | |
| Olympus America INC. | $22.17 | 2019 | |
| Amgen INC. | $21.64 | 2022 | |
| Palette Life Sciences, INC. | $21.08 | 2022 | |
| Blue Earth Diagnostics | $19.88 | 2019 | |
| Calyxo, INC. | $18.78 | 2024 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $17.93 | 2019 | |
| 180 Medical, INC. | $17.90 | 2024 | |
| Allergan, INC. | $16.11 | 2022 | |
| Medtronic USA, INC. | $15.46 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $14.65 | 2019 | |
| Urovant Sciences INC | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valal George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.